The Medinfo HIIG interface to the Reveos is a bidirectional interface, which was first developed by the Medinfo team for HMC in Qatar. It is similar to the Atreus interface but there are 4 units processed simultaneously in each cycle of operation whereas the Atreus only processed 1 unit each cycle. In Qatar it was used in conjunction with Mirasol riboflavin-based pathogen inactivation.
The process is:
- Medinfo controls registration, donor screening, and donor collection of whole blood and apheresis-derived (Trima) components.
- Medinfo will assign ISBT specimen labels for the whole blood collected with the Reveos blood kit.
- Medinfo will not allow processing of whole blood units not meeting donor criteria (donor screening, volumes, collection time, donor deferral database, etc.)
- Reveos will read ISBT specimen labels generated by Medinfo.
- Upon processing, Medinfo will receive from the Reveos machine the packed red blood cell, plasma, platelet, and buffy coat volumes for each bucket in the Reveos machine.
- If the volumes are within the specified ranges, platelet pooling and Mirasol pathogen inactivation of platelets and plasma may proceed.
For each component, the following information will be collected:
- All timestamps in the process
- Which Reveos machine used
- Which bucket in each machine used
- Volumes collected (packed RBCs, buffy coat platelet, plasma volume)
- Reveos collection set details
- Processing technologist ID
The key point is the complete TRACEABILITY of each component throughout its production. Should there be a failure in production, we can trace exactly where the problem is and then quarantine this and any other affected units simply in the system. Additionally, this information is part of the permanent record of the unit so it can retrieved subsequently at any time.